Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-aminobutyric acid (GABA) receptor subunit gamma is a component of the GABAA receptor, the primary inhibitory neurotransmitter receptor in the mammalian brain. It is a ligand-gated ion channel that mediates fast synaptic inhibition via chloride ion influx. The presence of the gamma subunit influences benzodiazepine binding and overall receptor function. Mutations are linked to neurological disorders like epilepsy.
Enhances GABA-mediated chloride ion influx
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid receptor subunit gamma.